ALB 10-Q report for 2025-09-30

Albemarle Corporation Form 10‑Q for quarter ended September 30, 2025 (unaudited). Reported net sales of $1,307,829 (thousands) for the three months and $3,714,702 (thousands) for the nine months ended September 30, 2025. Quarterly gross profit was $117,610 (thousands). The company recorded a $181,070 (thousands) goodwill impairment charge and restructuring/asset write-offs of $2,275 (thousands) in the quarter (compared with much larger restructuring charges in the prior-year period). Net loss attributable to Albemarle Corporation was $160,694 (thousands) for the quarter and net loss attributable to common shareholders (after mandatory convertible preferred dividends) was $202,382 (thousands), with basic loss per share of $1.72. Cash and cash equivalents were $1,931,758 (thousands) and total assets were $17,148,285 (thousands) as of September 30, 2025. Total long-term debt was $3,181,009 (thousands); total equity was $10,269,058 (thousands).

Sell. The 10‑Q shows continuing material losses at the consolidated level: a quarterly operating loss and a net loss attributable to Albemarle driven in part by a $181.07M goodwill impairment and meaningful restructuring/asset write-offs (prior period charge was substantially larger). While equity in net income of unconsolidated investments partially offsets operating losses, the company still reported a significant loss to common shareholders after mandatory convertible preferred dividends. Balance-sheet highlights include elevated goodwill and intangibles, meaningful long-term debt (~$3.18B) and a sizable preferred stock claim (Series A mandatory convertible preferred). Cash increased to ~$1.93B and operating cash flow for the nine months provided $893.8M, but recurring operating losses, impairment risk and the preferred dividend burden weigh on common equity returns. The filing is actionable for a cautious/sell stance pending further MD&A detail and forward guidance; review full 10‑Q notes and management discussion for drivers, impairment rationale, and liquidity plans before trade execution.

This excerpt is only the cover page/header of Sleep Number’s Form 10-Q for the quarter ended April 4, 2026. It contains filing metadata (issuer, ticker, exchange, address) but no financial statements, MD&A, guidance, risks, or operational commentary. As a result, it is not directly actionable for trading beyond confirming the filing exists.

The provided excerpt is only the cover/filing header of SoundHound AI, Inc.’s 10‑Q for the quarter ended 2026‑03‑31. It contains listing/security identifiers (SOUN, SOUNW) but no financial statements, MD&A, guidance, risk updates, liquidity details, or material events. As a result, there is insufficient information to form high-confidence, actionable bullish/bearish theses beyond generic “company filed its 10‑Q” metadata.

The provided excerpt is only the boilerplate cover/filing-status section of Teucrium Commodity Trust’s Form 10‑Q for period ended 2026‑03‑31, with no portfolio holdings, performance, risk, or material updates included. As-is, it contains no actionable investment information beyond confirming the existence of the filing and the issuer/ticker identity (WEAT).

The provided text is only the cover page of Archer Aviation’s Form 10‑Q for the quarter ended 2026‑03‑31 (issuer identity, exchange listing, and securities outstanding). It contains no operating/financial results, guidance, liquidity details, backlog, or risk-factor updates—so it is minimally actionable for trading beyond basic security identifiers and a generic dilution/optionality consideration from warrants.

This excerpt is essentially the cover page of CleanSpark, Inc.’s Form 10-Q for the quarter ended March 31, 2026. It contains identifiers (CIK/file no.), listing venue, and security descriptions (common stock and redeemable warrants with specific exercise terms), but no operating/financial results, guidance, risks, or MD&A detail. Actionability is therefore limited to capital-structure/dilution considerations around the listed warrant.

This excerpt of AST SpaceMobile’s 10‑Q is largely SEC cover-page/boilerplate (registrant info, exchange listing, filing compliance) and contains no financial results, guidance, liquidity, risk-factor updates, or operating metrics. As provided, it does not create a clear tradable catalyst beyond confirming continued reporting/listing status.

This excerpt only includes the cover page of Super Micro Computer, Inc.’s Form 10‑Q for the quarter ended March 31, 2026. It confirms the filing, issuer identity, listing (Nasdaq), and ticker (SMCI), but contains no financial results, guidance, risks, or MD&A content to support a directional investment view.

The provided text is only the cover/header portion of AbCellera Biologics Inc.’s Form 10‑Q for the quarter ended March 31, 2026 (identifying info, exchange listing, filing status). It contains no financial statements, guidance, risk updates, material events, MD&A, cash runway, pipeline/program updates, or disclosures that would support a differentiated trading view.